We are live on ! Find out more
NVAX icon

Novavax
NVAX

153 hedge funds and large institutions have $889M invested in Novavax in 2014 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 54 increasing their positions, 46 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

68% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 19

43% more capital invested

Capital invested by funds: $623M → $889M (+$266M)

17% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 46

7% more funds holding

Funds holding: 143 → 153 (+10)

74% less call options, than puts

Call options by funds: $2.17M | Put options by funds: $8.32M

Holders
153
Holders Change
+10
Holders Change %
+6.99%
% of All Funds
4.08%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
32
Increased
54
Reduced
46
Closed
19
Calls
$2.17M
Puts
$8.32M
Net Calls
-$6.15M
Net Calls Change
+$342K

Top Buyers

1
Invesco
Invesco
Georgia
+$5.14M
2
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
+$4.95M
3
BFA
BlackRock Fund Advisors
California
+$4.54M
4
Millennium Management
Millennium Management
New York
+$4.18M
5
Prudential Financial
Prudential Financial
New Jersey
+$4.12M

Top Sellers

1
CCM
Camber Capital Management
Massachusetts
-$14.4M
2
RCM
RA Capital Management
Massachusetts
-$9.54M
3
First Eagle Investment Management
First Eagle Investment Management
New York
-$2.08M
4
Ameriprise
Ameriprise
Minnesota
-$1.83M
5
State Street
State Street
Massachusetts
-$1.75M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$146M -$1.25M -11,935 -1%
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$73.4M +$2.43M +23,280 +4%
Invesco
3
Invesco
Georgia
$55.8M +$5.14M +49,137 +12%
BFA
4
BlackRock Fund Advisors
California
$52.9M +$4.54M +43,444 +11%
BB
5
BB Biotech
Switzerland
$46.8M +$2.09M +20,000 +5%
Vanguard Group
6
Vanguard Group
Pennsylvania
$43.6M +$1.43M +13,679 +4%
Wells Fargo
7
Wells Fargo
California
$42.1M -$1.09M -10,420 -3%
State Street
8
State Street
Massachusetts
$39.2M -$1.75M -16,775 -5%
BIT
9
BlackRock Institutional Trust
California
$38.6M -$721K -6,895 -2%
Wellington Management Group
10
Wellington Management Group
Massachusetts
$25.7M +$1.59M +15,187 +8%
BNP Paribas Asset Management
11
BNP Paribas Asset Management
France
$22.5M -$213K -2,040 -1%
Franklin Resources
12
Franklin Resources
California
$19.9M -$1.36M -13,020 -7%
RCM
13
RA Capital Management
Massachusetts
$19.2M -$9.54M -91,300 -36%
Northern Trust
14
Northern Trust
Illinois
$15.6M -$534K -5,110 -4%
NC
15
Northpointe Capital
Michigan
$13.4M +$1.01M +9,620 +9%
CCM
16
Camber Capital Management
Massachusetts
$11.9M -$14.4M -137,500 -58%
EAM
17
Eventide Asset Management
Massachusetts
$11.3M – – –
CAM
18
Cormorant Asset Management
Massachusetts
$8.89M – – –
CS
19
Credit Suisse
Switzerland
$8.82M -$83.2K -796 -1%
Bank of New York Mellon
20
Bank of New York Mellon
New York
$8.33M -$523 -5 -0%
Morgan Stanley
21
Morgan Stanley
New York
$8.19M -$109K -1,045 -1%
Geode Capital Management
22
Geode Capital Management
Massachusetts
$8.1M +$183K +1,754 +3%
Ameriprise
23
Ameriprise
Minnesota
$7.32M -$1.83M -17,524 -22%
BBA
24
Baker Bros. Advisors
New York
$7.25M – – –
CNB
25
City National Bank
California
$6.43M +$475K +4,548 +9%
1
2 3 4 5

NVAX Hedge Fund Activity: Q4 2014 in Review

153 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Novavax (NVAX) for Q4 2014, worth a combined $889M — up 43% from $623M a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new NVAX positions and 19 closed out — a net gain of 13 holders — while 54 added to existing stakes and 46 trimmed.

The largest buyer was Invesco, adding an estimated $5.14M. The largest seller was Camber Capital Management, cutting an estimated $14.4M.

  • 153 institutional investors held Novavax (NVAX) as of Q4 2014, up from 143 in Q3 2014.
  • Funds reported $889M of Novavax stock for Q4 2014, up 43% quarter-over-quarter.
  • 32 funds opened new Novavax positions in Q4 2014 and 19 closed out, a net change of +13 holders.
  • The largest Novavax buyer in Q4 2014 was Invesco, an estimated $5.14M added.
  • The largest Novavax seller in Q4 2014 was Camber Capital Management, an estimated $14.4M sold.

Based on aggregated 13F filings for Q4 2014.